European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Candace Johnson

President

Past deals in Early Venture Stage

Astrape Networks

Grant in 2025
Astrape powers the future of datacenters: more bandwidth, less power.

Sparrow Quantum

Series A in 2025
Sparrow Quantum Aps. is a Danish company specializing in quantum technology, particularly in the development of advanced light-matter interfaces. The firm focuses on creating deterministic single-photon sources, which are essential for various quantum technologies. Sparrow Quantum boasts the highest efficiency for on-chip single-photon sources globally, characterized by exceptional photon purity, indistinguishability, and outcoupling capabilities. This cutting-edge technology is rooted in over twenty years of research at the renowned Niels Bohr Institute in Copenhagen, from which the company holds exclusive licenses for key patents. By leveraging self-assembled quantum dots paired with slow-light photonic-crystal waveguides, Sparrow Quantum enhances light-matter interactions, providing critical advancements for its clients in the field of photonic quantum technology.

PrecisionLife

Grant in 2025
PrecisionLife is a company focused on advancing precision medicine by leveraging its proprietary artificial intelligence platform to enhance the understanding of chronic diseases. It specializes in patient stratification, which allows for the identification of novel subgroups within patient populations, thereby generating insights that inform the discovery of new drug targets and drug repositioning candidates. By utilizing unique and patentable biomarkers, PrecisionLife connects patients with specific disease sub-groups and potential therapies, ultimately aiming to create personalized treatment alternatives. The company’s innovative approach not only drives advancements in biopharmaceuticals but also seeks to improve patient outcomes, enabling individuals to lead longer and healthier lives.

Deeploy

Grant in 2025
Deeploy is a developer of a machine learning operations platform focused on enhancing the accountability and transparency of AI systems. The platform centralizes explainable AI (XAI) within machine learning operations (MLOps), empowering users to comprehend how models function and to rectify automated decisions when necessary. By organizing deployments, tracking model performance, generating trace logs, and facilitating the creation of custom models and explainers, Deeploy provides data scientists and users with the tools needed to understand the implications and applications of machine learning models. This approach ensures that AI systems are both trustworthy and accountable.

TENSIVE

Series A in 2025
Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to offer a natural breast reconstruction or augmentation.Tensive is a biomedical startup established in 2012 to develop innovative prostheses aiming to offer a natural breast reconstruction or augmentation.

Hervolution Therapeutics

Series A in 2024
Hervolution Therapeutics focuses on developing first-in-class immunotherapies to combat tumors from within. The company leverages Human Endogenous Retroviral proteins (HERVs) to create rationally designed immune therapeutics targeting the dark genome. Hervolution Therapeutics aims to address hidden enemies within the human body by pioneering innovative biotechnology solutions.

Hideez

Grant in 2024
Hideez is a cybersecurity startup that specializes in providing solutions for both physical and logical access. With offices in the USA and Ukraine, the company has developed the Hideez Key, a hybrid device designed for wireless authentication and password management. This innovative solution integrates RFID door credentials and digital signatures, utilizing encrypted Bluetooth, RFID, and NFC technologies. Hideez Key offers a versatile approach to authentication, enabling users to manage and replace credentials remotely. Its proprietary encryption protocols are platform agnostic and are designed to enhance existing solutions in the market. Overall, Hideez aims to simplify identity and access management while ensuring the security of digital assets.

Reverion

Series A in 2024
Reverion specializes in developing reversible, carbon-negative power plants that leverage patented technology to maximize the potential of biogas. The company's containerized units, designed for mass production, achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. This innovative approach not only doubles the electricity output of traditional gas engines but also significantly reduces greenhouse gas emissions, resulting in a negative CO2 balance. Additionally, Reverion's technology is capable of utilizing excess solar and wind power, enhancing electricity production in existing biogas plants and stabilizing the power grid during electrolysis. Through these advancements, Reverion aims to promote a renewable and decarbonized energy future.

Oryl Photonics

Grant in 2024
Oryl Photonics develops a laboratory instrument for pharmaceutical and biotech companies that provides simple, reliable, cost-effective and sustainable solubility measurement to accelerate drug development for better and effective medicine.

MediWound

Grant in 2024
MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.

Endoron Medical

Series A in 2024
Endoron Medical specializes in the development of medical devices aimed at improving the treatment of abdominal aortic aneurysms. The company focuses on creating an endovascular suture device that enhances the effectiveness of endovascular aneurysm repair procedures. By designing long-lasting sealing equipment for endografts, Endoron Medical provides healthcare professionals with advanced technology to treat patients more effectively. This innovation is intended to improve patient outcomes and streamline surgical processes in the management of abdominal aortic aneurysms.

Innatera

Series A in 2024
Innatera is an innovative developer of ultra-low power neuromorphic processors designed to enhance the efficiency of sensor data processing. Established in 2018 as a spin-off from the Delft University of Technology, the company focuses on creating processors that replicate the brain's mechanisms for sensory perception. Utilizing a novel continuous-time analog-mixed signal processing architecture, Innatera's chips can process sensor data up to 100 times faster while consuming up to 500 times less energy compared to traditional processors. This technology enables businesses to access and analyze sensor data more effectively, positioning Innatera as a leader in the field of energy-efficient computing solutions.

Qblox

Series A in 2024
Qblox is a Dutch scaleup focused on quantum technology, specializing in the development of control hardware for quantum computers. The company offers patented, modular control systems that integrate hardware and software solutions designed to enhance the management of qubits. By creating a distributed processor architecture, Qblox simplifies experimental setups while improving gate fidelities through advanced electronics that reduce noise and drift. This innovation enables scientists to minimize crosstalk, implement low-latency control flows, and optimize measurement efficiency, addressing significant scientific and engineering challenges in the evolution of quantum computing. Qblox aims to support the transition from prototype quantum computers to powerful computational systems, thereby contributing to the broader advancement of quantum technology.

King's College London

Grant in 2024
King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.

Bank of Memories

Grant in 2024
Bank of Memories helps to organize memories and documents and pass them on to the right people.

ProFuse Technology

Grant in 2024
ProFuse Technology specializes in advancing cultured meat production by enhancing methods and efficiency. The company has developed innovative technology that significantly reduces production time while improving meat quality and increasing yields. By accelerating muscle fiber growth, ProFuse enables meat producers to enhance their production capacity and lower costs, making cultured meat more accessible and sustainable.

Vitestro

Series A in 2024
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.

Vitestro

Grant in 2024
Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.

DRONAMICS

Grant in 2024
DRONAMICS is a cargo drone airline that develops drone technology for cargo transportation and logistics operations. The company is building an air cargo ecosystem to cater to the requirements of individuals and industries across the globe. This mobility solution, driven by long-range cargo drones, delivers savings in time, costs, and carbon emissions.

Multiverse Computing

Series A in 2024
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.

Smart Farm Robotix

Grant in 2024
Smart Farm Robotix manufactures agricultural robots that handle the difficulties of manual weeding, herbicide use, and machine weeding.

FreezeM

Series A in 2024
FreezeM is focused on advancing preservation technologies that enhance the use of insects as a sustainable protein source for the animal feed industry. The company is developing innovative methods for large-scale freezing of insects, which will facilitate the creation of global stocks of frozen insect neonates and eggs. This approach aims to address critical challenges related to the availability, cost, and regulatory hurdles associated with utilizing insects in animal feed. By ensuring a stable and year-round production of these beneficial insects, FreezeM seeks to make a significant impact on the animal feed market, while also contributing to biological pest control and species preservation.

Daze

Series A in 2024
Daze is an Italian hi-tech startup developing smart chargers for electric vehicles (EVs). Founded in 2016, Daze spent 3 years mainly focusing on pure R&D activities to create the first both autonomous and conductive charger for EVs: DazePlug. During 2020 Daze has also developed, started to produce and sell two “classic” EV charging products: DazeBox (for home charging) and DazeMax (for shared charging). In 2021 product sales exceeded 3,800 units and revenues approached 1.9 million Euro, with CAGR of 330% between 2019 and 2021. From June 2021 the company is also benefitting from a grant of 2.5 million Euro from the European Innovation Council (EIC) Fund, which is and will be used to push forward DazePlug development. In 2022 revenues grow over 5 million Euro with positive EBITDA, Daze Iberica started the operations. 2023 is the year of expansion, Daze France is starting the operations and new business models and new products are added to the business

Aldoria

Series A in 2024
Aldoria specializes in space situational awareness, focusing on the collection, processing, and utilization of data to protect critical assets in space. The company addresses the growing challenges of space sustainability caused by increasing amounts of space debris and traffic. Its services encompass the detection, tracking, cataloging, and risk assessment of artificial satellites and space debris. By actively monitoring these elements, Aldoria helps operators and space organizations avoid potential hazards and adjust orbital paths, ultimately contributing to safer and more sustainable space operations. The company also provides users with a modern situational awareness platform and detailed sustainability reports.

NETRIS Pharma

Series A in 2023
NETRIS Pharma S.A.S. is a biotechnology company based in Lyon, France, that specializes in identifying and developing therapeutic molecules aimed at treating cancer. The company's innovative approach focuses on targeting dependence receptors, which are trans-membrane proteins that play a crucial role in signaling within cells and regulating tumor development. NETRIS Pharma offers both in vitro and in vivo research services, along with preclinical practices, to advance drug manufacturing for various types of cancer, including breast cancer, lung cancer, glioblastoma, and neuroblastoma. Founded in 2008, the company is dedicated to contributing to the pharmaceutical industry by developing novel cancer therapies.

Lotus Microsystems

Series A in 2023
Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug and play solutions enable our customers to innovate their electronics without worrying about power supply units.

respiQ

Grant in 2023
RespiQ is a healthtech startup that specializes in portable, non-invasive breath analysis technology aimed at the early detection and management of respiratory diseases. By utilizing advanced emission spectroscopy and artificial intelligence, RespiQ's device identifies volatile organic compounds (VOCs) in breath, enabling real-time detection of conditions such as COPD exacerbations. The company's focus on affordability, portability, and user-friendliness seeks to democratize access to advanced diagnostics, ultimately improving patient outcomes and reducing healthcare costs. In addition to respiratory diseases, RespiQ's versatile platform has potential applications for asthma, lung cancer, and infectious diseases. The company also offers an app that provides personalized health insights and dietary guidance, allowing users to monitor their health proactively. RespiQ's combination of technical and healthcare expertise positions it as a leader in breath diagnostics, with a commitment to enhancing overall health and well-being.

NEOGAP Therapeutics

Grant in 2023
NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

ACORAI

Grant in 2023
Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.

RAIKU Packaging

Grant in 2023
RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.

SolasCure

Grant in 2023
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

VSORA

Grant in 2023
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.

FarmInsect

Series A in 2023
FarmInsect GmbH, founded in 2019 and based in Bergkirchen, Germany, specializes in automated insect breeding systems designed to provide a sustainable and efficient source of animal feed. The company focuses on enabling local farmers to produce insect larvae from organic residues, which can be used as protein feed for livestock such as chickens, pigs, and fish. By offering a solution that replaces imported soy and fishmeal with locally sourced insect protein, FarmInsect aims to enhance the sustainability of animal husbandry while ensuring that farmers have a consistent supply of young larvae each week for their feeding needs.

PASQAL

Grant in 2023
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

PrediSurge

Series A in 2023
PrediSurge is a software company that offers design and support solutions for physicians and medical device companies.

Kern Tec

Series A in 2023
Kern Tec specializes in upcycling fruit kernels from stone fruits, specifically cherries, apricots, and plums, to create innovative food products. The company refines these kernels into high-quality raw materials suitable for various applications, including baking ingredients, sustainable cosmetic oils, fertilizers, and biomass. By focusing on environmentally friendly processes, Kern Tec provides clients in the baking, food supplement, dairy alternatives, and confectionery industries with naturally sourced materials, promoting sustainability while meeting industry demands.

Bound4Blue

Series A in 2023
bound4blue developes foldable and autonomous wingsail system to be integrated onto a wide range of vessels. The system has been conceived as a complementary propulsion system, which produces effective thrust from existing winds, reducing the main engine power required and, therefore, delivering fuel consumption and pollutant emissions reductions of up to 40% and it ensures a payback period under 5 years.

Paptic

Series A in 2023
Paptic is a manufacturing company focused on creating innovative, wood-based materials that serve as sustainable alternatives to traditional paper and plastic products. By developing renewable and recyclable bags, Paptic addresses the pressing issue of plastic waste accumulation in the environment. The company’s products combine the eco-friendly properties of paper with the practical functionality of plastics, allowing customers to meet their everyday needs while contributing to a more sustainable environment.

STABL

Venture Round in 2023
Stabl Energy is a developer focused on enhancing battery storage systems through innovative technology. The company creates virtual battery inverters that facilitate the integration of energy storage with renewable energy sources. By manufacturing central inverters that connect to the power grid, Stabl Energy aims to minimize self-consumption of battery storage, addressing challenges such as high battery voltage and enabling clients to fully utilize their battery capacity. This approach not only maximizes energy efficiency but also sets a new standard for the deployment of energy storage solutions in the renewable energy sector.

Pulse

Grant in 2023
Pulse is a platform for furthering our understanding of bioprinting and its applications in space exploration and medicine.

ELGAN Pharma

Grant in 2023
Elgan Pharma is a biotechnology company specializing in neonatology, dedicated to addressing medical challenges and developmental issues faced by premature infants. The company is focused on developing innovative therapies utilizing nanotechnology to prevent visual impairment, a common and multifactorial problem in preterm babies. By targeting the specific needs of this vulnerable population, Elgan Pharma aims to enhance visual outcomes and reduce the risk of significant disabilities, ultimately supporting healthcare professionals in their efforts to improve the quality of life for these infants.

Cellbox Solutions

Grant in 2023
Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.

Woodio

Grant in 2023
Woodio is a design-oriented company that specializes in innovative material technology for bathroom applications. The firm has developed a fully waterproof wood composite made from real wood chips, allowing for a range of design options while prioritizing sustainability. This technology offers customers fully recyclable biomaterials, enabling them to enhance and redesign their bathrooms with eco-friendly solutions. Woodio's focus on combining aesthetics with functionality positions it as a unique player in the market for bathroom design materials.

EBAMed

Series A in 2023
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

Escala Medical

Grant in 2023
Escala Medical is focused on developing a minimally invasive medical device aimed at treating pelvic organ prolapse (POP) in women. The company's innovative system offers a nonsurgical, incision-free, and mesh-free repair option that addresses the vaginal apex by connecting it to the sacrospinous ligament. This approach is designed to be safe, quick, and to preserve organ functionality while minimizing patient discomfort. The procedure can be performed in outpatient and office-based settings, providing a much-needed alternative for women suffering from POP.

TreaTech

Series A in 2023
TreaTech is a Swiss Cleantech company founded in 2015 by engineers from the École Polytechnique Fédérale de Lausanne (EPFL). The company focuses on developing innovative treatment technology aimed at addressing the challenges of wastewater management. Its catalytic hydrothermal gasification (HTG) system provides an eco-friendly solution for the disposal of various liquid wastes, such as sewage sludge, which are typically incinerated or sent to landfills. This advanced thermochemical process transforms these wastes into valuable by-products, including renewable gas, clean water, and mineral salts that can be further upgraded into fertilizers. TreaTech's approach aligns with sustainable development goals and the principles of a circular economy, enabling clients to benefit from efficient wastewater treatment while recycling essential resources.

DTE ehf

Series A in 2023
DTE introduces breakthrough real-time process control analytics for metals production and processing towards Industry 4.0, through our robotic hardware and software solutions, automating current manual sampling processes for improved quality, cost, efficiency and safety.

Sensoneo

Series A in 2023
Sensoneo is a provider of advanced smart waste management solutions that assist cities and businesses in managing waste more efficiently and sustainably. The company utilizes proprietary ultrasonic sensors to monitor waste levels in real-time, coupled with sophisticated software that facilitates data-driven decision-making and optimizes waste collection processes. This technology enables significant reductions in waste collection costs, with improvements in operational efficiency and a potential decrease in carbon emissions. Sensoneo's solutions have been implemented in various locations across Europe, North America, South America, the Middle East, Australia, and New Zealand, attracting a diverse range of clients seeking to enhance their waste management practices. By automating the waste lifecycle and promoting eco-friendly initiatives, Sensoneo aims to transform traditional waste management into a more transparent and responsible process.

Cupffee

Grant in 2023
Cupffee specializes in the production of edible and biodegradable coffee cups and stirrers, offering a sustainable alternative to traditional disposable cups. Their manufacturing process is environmentally friendly, generating no industrial waste and only producing clean steam along with the pleasant aroma of freshly baked cookies. Additionally, any leftover materials from the cup production are repurposed as ingredients for other edible products, further enhancing their commitment to sustainability. Unlike conventional disposable cups, Cupffee's products decompose within days, allowing consumers to dispose of them in an environmentally responsible manner.

VCG.AI

Grant in 2023
The Intelligence Behind Global Circularity VCG.AI transforms industrial by-products and waste into valuable resources. AI-powered development of circular economy business models with the latest technology, material, market, and regulatory insights. Their proprietary AI solution, the Value Chain Generator®, helps companies, cities, and regions accelerate the transition to a circular economy, through Valorisation of By-products and Waste, Circular Product Development, Regional Circular Opportunities Assessment. When organisations want to better valorise by-products and waste, develop or source circular materials, or enhance circularity in their value chains, VCG.AI analyses thousands of data points to deliver the optimal solution tailored to their specific needs and locations. What once took months or years can now be achieved in just weeks—without the need to hire additional technology or bioeconomy experts. VCG.AI’s ever-expanding system includes: - 650+ validated circular solutions - 150+ different proven valorisation technologies - 3.5 M companies - 4M tons of project-ready organic residuals across Europe VCG.AI is on a mission to accelerate the transition to a circular economy by unlocking circular opportunities for businesses worldwide. Learn more about them at www.vcg.ai.

3DSecret

Grant in 2023
3DSecret is developing cutting-edge technologies to uncover the stochastic patterns behind metastasis in order to predict the course of cancer.

Norbite

Grant in 2023
Norbite is a biotech research firm that transforms plastic waste into sustainable goods using an insect-based biorefinery.

Agurotech

Grant in 2023
Agurotech develops soil sensing technology. They offer products that include robust and highly reliable sensing technology, tailored irrigation recommendations, and continuous improvement of the irrigation process.

Inobiostar

Grant in 2023
Inobiostar focuses on research and experimental development services.

EyeLights

Series A in 2023
EyeLights specializes in innovative motorcycle accessories by offering a Head Up Display GPS that enhances rider safety and experience. This device projects crucial navigation and safety information directly into the rider's line of sight, allowing them to maintain focus on the road. It alerts users to potential hazards such as dangerous bends, nearby obstacles, and speed limit violations. Designed for quick installation on various types of helmets, the EyeLights product can be set up in under five minutes. Its compact optical technology ensures visibility of GPS data from over two meters away and supports audio functions for up to eight hours. The device is adaptable to sun visors, resistant to rain and fog, and lightweight, weighing less than 100 grams, making it a practical choice for motorcycle enthusiasts seeking enhanced situational awareness while riding.

Naco

Grant in 2023
Naco Technologies Ltd specializes in the development, manufacturing, and supply of advanced nano coating technologies to a global clientele. Founded in 2009 and based in Riga, Latvia, the company offers a variety of high-performance coatings, including oil-enhanced, wear-protective, thermal barrier, and liquid-repellent solutions tailored for industries such as tooling, automotive, aerospace, and micro-chip production. In recent years, Naco has focused on supporting the hydrogen sector by building a manufacturing facility that provides ready-to-use coated parts for hydrogen production systems. By developing multilayer and multicomponent coatings specifically for green hydrogen applications like electrolyzers and fuel cells, Naco aims to enhance the reliability of these systems while minimizing the need for costly and scarce materials. In 2015, Naco was acquired by the Schaeffler Group, a Germany-based company.

Smart Immune

Grant in 2023
Smart Immune is a clinical-stage biotechnology company focused on developing innovative hematopoietic stem cell-based therapies aimed at improving the prognosis and quality of life for patients with serious diseases. The company's primary program utilizes T cell progenitors, known as ProTcells, which are designed to facilitate a rapid and safe immune recovery following transplantation. This therapy seeks to provide a polyclonal immune response, enhancing the body's ability to combat cancers and infections. Additionally, Smart Immune plans to complement its core offerings with advancements in targeted conditioning, gene therapy, and genome editing, thereby creating next-generation treatments for a range of inherited blood disorders and hematological malignancies.

Nemysis

Grant in 2023
Nemysis Limited is a specialty pharmaceutical company founded in 2005 and based in Dublin, Ireland. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a unique staged approach to product development. Nemysis manufactures a range of food supplements, medical matrix products, and prescription items, targeting the same medical conditions across different market segments. Notable products include a novel gastric and trypsin-resistant formulation designed for oral enzymatic therapy in patients with celiac disease, as well as an iron supplement that acts as a medical device to neutralize gluten, aimed at alleviating symptoms for individuals with celiac disease and non-celiac gluten sensitivity. This strategy allows Nemysis to cater to patients with iron deficiency or anemia while minimizing gastrointestinal side effects associated with traditional iron supplementation.

Samplix

Grant in 2023
Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Miwa

Grant in 2023
Miwa is a retail solution provider focused on minimizing single-use packaging through a circular economy strategy. The company offers a system that includes reusable containers designed to reduce waste and promote sustainability. These sealable and reusable containers work alongside electronic dispensers located in retail environments, facilitating the bulk distribution of both food and non-food products. By enabling producers and retailers to store and dispense items in a hygienic manner, Miwa aims to create a more efficient and environmentally friendly approach to retail.

GrayMatters Health

Grant in 2023
GrayMatters Health delivers beyond the pill digital therapeutics for mental disorders through volitional regulation of brain processes.

Qurv

Grant in 2023
Qurv develops wide-spectrum image sensor technologies and integrated solutions to enable next-gen computer vision applications, addressing the expanding needs of an autonomous and intelligent new world. Qurv's technology leverages current CMOS scalable manufacturing and advanced materials to unlock new levels of performance, reliability and function in XR devices, service robots and automotive. Qurv's breakthrough technology platform stemmed from more than eight years of applied research, and the company was established in 2020.

Sunrise

Series A in 2023
Sunrise focuses on addressing the widespread issue of sleep disorders, particularly sleep apnea, which affects nearly one billion people globally. The company has developed a 3-gram sensor that provides a rapid, at-home diagnosis of sleep apnea, utilizing trigeminal drive analysis to detect respiratory events. This certified medical device connects seamlessly to a smartphone, allowing for easy use and immediate results. Clinical studies have demonstrated that Sunrise's technology matches the accuracy of traditional in-lab sleep studies but at a significantly lower cost. After testing, patients can consult with certified sleep doctors online or visit local sleep centers, streamlining the diagnostic process. With a large percentage of sleep apnea cases remaining undiagnosed, Sunrise offers a crucial solution for patients, caregivers, and insurers, enhancing the accessibility and efficiency of sleep disorder diagnostics.

IDloop

Grant in 2023
IDloop specializes in biometric technology, focusing on contactless fingerprint sensor solutions tailored for both business and government markets. The company’s innovative technology captures secure three-dimensional images of multiple fingers, which significantly reduces false acceptance rates and enhances overall security. By leveraging advanced 3D imaging, artificial intelligence, and embedded technology, IDloop aims to provide efficient and reliable biometric identification, addressing the growing demand for secure access solutions in various sectors.

Valo Therapeutics

Grant in 2023
Valo Therapeutics is an immunotherapy company based in Oxford, United Kingdom, with an additional office in Helsinki, Finland. Founded in 2016, the company focuses on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Its primary platform, PeptiCRAd, is an engineered human oncolytic adenovirus designed to stimulate a systemic anti-tumor T cell response. This innovative approach enables the conversion of oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without the need for multiple genetically modified viruses. Additionally, Valo Therapeutics is working on other strategies, such as PeptiENV, to enhance therapeutic responses to enveloped oncolytic viruses across various cancer types. By utilizing tumor-specific peptides, the company aims to elicit a robust adaptive immune response, potentially providing lasting immunity against multiple cancers and improving patient outcomes.

TILT Biotherapeutics

Grant in 2023
TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.

NANDO

Grant in 2023
We make waste management simpler by providing data in an accessible, clear and efficient way to environmental professionals. NANDO, is a cutting-edge artificial intelligence, that delivers actionable insights for measuring, analyzing, and optimizing waste management. This empowers companies and communities to minimize their waste impact, safeguarding the planet for future generations.

Efficient Energy Technology

Grant in 2023
Efficient Energy Technology makes renewable energy simple, safe, and dependable for everyone. Efficient Energy Technology develops a small power plant consisting of photovoltaic and storage for complete self-installation.

Sostre Cívic

Grant in 2023
Sostre Cvic is a non-profit organization that promotes an alternative model of housing access under the scheme.

HSL Technologies

Series A in 2023
HSL Technologies specializes in innovative hydrogen transport and storage solutions, centered around a breakthrough product known as HydroSil. This technology allows hydrogen to be safely transported using conventional infrastructures, thereby minimizing risk. The company has designed a hydrogen-based liquid carrier that enables efficient charging and releasing of hydrogen, offering a stable, non-toxic, and non-explosive fuel alternative. This liquid carrier generates no emissions, making it an environmentally friendly option for various applications, including fuel cells that produce electricity for vehicles, generators, and portable devices. HSL Technologies is committed to driving the transition to a carbon-free future, positioning itself as a leader in the clean energy sector.

Kvantify

Grant in 2023
Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Iris.ai

Grant in 2023
Iris.ai offers an AI-powered science assistant designed to enhance the efficiency of research and development departments by facilitating the navigation of scientific literature. Its primary product, RSpace, features advanced search capabilities, smart filters, reading list analysis, auto-generated summaries, and automated data extraction, enabling users to systematically organize information. By leveraging natural language processing algorithms, Iris.ai addresses the challenges of factuality tracking in AI, providing tools that enhance the accuracy and reliability of scientific research. This platform is aimed at both corporate R&D teams and academic researchers, allowing them to uncover new scientific insights that go beyond traditional human capabilities.

iLoF

Grant in 2023
iLoF, or Intelligent Lab on Fiber, is a developer of a digital health platform that utilizes advanced photonics and artificial intelligence to enhance personalized drug discovery and development. The company has created a patented system that identifies and captures unique features of gold-standard biomarkers, compiling this information into a cloud-based library. By leveraging this extensive database, iLoF aims to facilitate collaboration among physicists, biologists, and data scientists, ultimately improving the efficiency and patient-centricity of clinical trials. This innovative approach not only reduces the costs associated with drug development but also aims to provide patients with tailored, life-saving treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.